HOME >> BIOLOGY >> NEWS
'Injectable' tissue implant could repair ravages of breast cancer surgery

Clemson University researchers have developed an injectable tissue implant that could be used to repair damage caused by breast cancer surgeries.

The work is headed by Karen Burg, a Clemson bioengineer just named to MIT's Technology Review 100 top innovators list. Burg's work with injectable transplants could one day provide breast-cancer patients a viable reconstructive surgical solution for damage left by lumpectomies and other invasive procedures. The implant, made of donor cells grown onto tiny beads, could reduce scarring, help restore the breast's natural shape and promote quicker surgical recoveries, said Burg, a Clemson alumna recruited to Clemson four years ago to help develop its tissue engineering program.

"It's thrilling to be a part of a project that could have such a profound impact on women's lives," said Burg, an associate bioengineering professor.

The research calls for cells to be grown on a scaffolding of tiny beads, then mixed with a gel and injected into the human body. Gel and beads are absorbed, leaving only the cells, which grow to fill the damaged area.

If the testing goes well, the injectable transplant technology could be ready for use in humans within 10 to 15 years. Burg's work could provide the first permanent biologically based reconstructive solution for breast-cancer survivors. The need is immense: An estimated 74,000-plus American women undergo breast reconstructions each year to repair damage from invasive procedures such as lumpectomies and mastectomies.

Burg's research also has potential in bone reconstruction and spinal disc repair. Treatment of patients with tissue and organ failure, which includes bone, accounts for approximately 50 percent of a total health care cost of $400 billion in the United States.

Burg's research has drawn wide attention from the scientific community.

In September, Technology Review, MIT's Magazine of Innovation, named Burg to its 2003
'"/>

Contact: Sandy Dees
sdeesba@clemson.edu
864-655-4193
Clemson University
1-Oct-2003


Page: 1 2

Related biology news :

1. Molecular motor implicated in tissue remodeling
2. Tufts University establishes $4 million dollar tissue engineering resource center
3. Single isolated mouse skin cell can generate into variety of epidermal tissues
4. Patented process preserves transplant tissues/organs
5. U-M scientists find common virus in human prostate tissue
6. Cell study leap forward for tissue engineering, diseases
7. Growing replacement teeth and dental tissues
8. Jefferson researchers develop microchip to track genetic signature of cancer and normal tissue
9. DCI donor services begins distribution of tissue implants
10. Embryonic stem cell - based tissue engineering may help repair damaged heart muscle
11. Researchers use novel technology to extract RNA from archive formalin-fixed paraffin-embedded tissue

Post Your Comments:
(Date:10/16/2014)... 2014) – Post-menopausal women experienced improvements in vaginal ... or genital bleeding, after 12 weeks of daily ... soy germ-based nutritional supplement previously shown to help ... peer-reviewed pilot study reported in a poster at ... meeting. , "These data documented improved vaginal ...
(Date:10/15/2014)... non-traditional biophysics textbook and it describes how life functions ... discovery into biological systems and provides an understanding of ... about how our genes make proteins that control the ... in an organism. It quantifies the principles of life ... found on both large and small scales. The book ...
(Date:10/15/2014)... SHELTON, Conn. , Oct. 15, 2014 NXT-ID, Inc. ... a biometric authentication company focused on the growing mobile commerce market ... NASDAQ MarketSite in Times Square on Monday October 13 th . ... with CTO David Tunnel and angel investor Mr. ... Gino Pereira , CEO of NXT-ID thanked his investors and employees ...
Breaking Biology News(10 mins):S-equol supplements associated with improved measures of reproductive health in postmenopausal women 2New book about life as seen from physics 2Photo Release: NXT-ID Inc. Rings Opening Bell of the NASDAQ Stock Market October 13th 2Photo Release: NXT-ID Inc. Rings Opening Bell of the NASDAQ Stock Market October 13th 3
(Date:10/22/2014)... , Oct. 22, 2014  Actavis plc (NYSE: ... and Rhythm, a biopharmaceutical company, today announced that Actavis ... wholly owned subsidiary, Rhythm Health, Inc., which is developing ... of diabetic gastroparesis and other GI functional disorders. ... trial of relamorelin for the treatment of diabetic gastroparesis ...
(Date:10/22/2014)... Involution Studios , a healthcare software design ... Understanding Ebola . The goal of the ... follow informative tool for anyone wanting to know more ... , "As the news has spread in all directions ... not only a healthcare crisis with global impact, but ...
(Date:10/22/2014)... 2014 Physicians Choice Laboratory Services ... menu, which enables healthcare providers to individualize therapeutic ... evidence-based results, healthcare providers are better able to ... while minimizing risks for adverse drug reactions and ... the FDA [1] more than 2.2 million adverse ...
(Date:10/22/2014)... , Oct. 22, 2014 Nuvilex, Inc. ... approximately 400 million people worldwide are living with diabetes, ... people by 2030.  The global market for diabetes treatments ... approximately 330,000 people worldwide died from pancreatic cancer.  Pancreatic ... due to cancer in the United States ...
Breaking Biology Technology:Actavis Signs Option to Acquire Rhythm Subsidiary and its GI Development Product, Relamorelin 2Actavis Signs Option to Acquire Rhythm Subsidiary and its GI Development Product, Relamorelin 3Actavis Signs Option to Acquire Rhythm Subsidiary and its GI Development Product, Relamorelin 4Actavis Signs Option to Acquire Rhythm Subsidiary and its GI Development Product, Relamorelin 5Involution Studios' Ebola Infographic Provides Key Disease Information and Statistics at a Glance 2PCLS Announces Expansion of Cardiovascular Pharmacogenetic Testing Menu 2PCLS Announces Expansion of Cardiovascular Pharmacogenetic Testing Menu 3Nuvilex Brief Analyst Report: Thinking Outside the Box by BrokerBank Securities, Inc. 2
Cached News: